Literature DB >> 10453468

Galanin and galanin receptors.

T P Iismaa1, J Shine.   

Abstract

The development of a strain of galanin knockout mice has provided confirmation of a neuroendocrine role for galanin, as well as supporting results of previous physiological investigations indicating a role for galanin in analgesia and neuropathic pain, and potentially in neuronal growth and regeneration processes. Whether elevation of galanin expression in neurodegenerative disorders such as Alzheimer's disease represents a survival response or exacerbates functional deficit in afflicted individuals remains to be determined. More detailed analysis of the phenotype of the galanin knockout mouse should provide insights into the physiological role of galanin in memory and learning processes, as well as in hypothalamic function and other aspects of neuroendocrine regulation. Biochemical and molecular cloning efforts have demonstrated that the multiplicity of actions of galanin is matched by complexity in the distribution and regulation of galanin and its receptors. A focus on characterisation of galanin receptors has resulted in the molecular cloning of three receptor subtypes to date. The distribution and functional properties of these receptors have not yet been fully elucidated, currently precluding assignment of discrete functions of galanin to any one receptor subtype. It is not currently possible to reconcile available pharmacological data using analogs of galanin and chimeric peptides in functional assay systems with the pharmacological properties of cloned receptor subtypes. This highlights the value of further knockout approaches targeting galanin receptor subtypes, but also raises the possibility of the existence of additional receptor subtypes that have yet to be cloned, or that receptor activity may be modulated by regulatory molecules that remain to be identified. The development of receptor subtype-specific compounds remains a high priority to advance work in this area. The ability to selectively modulate the many different actions of galanin, through a clearer understanding of receptor structure-function relationships and neuronal distribution, promises to provide important insights into the molecular and cellular basis of galanin action in normal physiology, and may provide lead compounds with therapeutic application in the prevention and treatment of a range of disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10453468     DOI: 10.1007/978-3-540-49421-8_12

Source DB:  PubMed          Journal:  Results Probl Cell Differ        ISSN: 0080-1844


  15 in total

1.  Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test.

Authors:  Takashi Yoshitake; Fu-Hua Wang; Eugenia Kuteeva; Kristina Holmberg; Masatoshi Yamaguchi; Jacqueline N Crawley; Robert Steiner; Tamas Bartfai; Sven Ove Ogren; Tomas Hökfelt; Jan Kehr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-30       Impact factor: 11.205

2.  Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).

Authors:  R Tofighi; B Joseph; S Xia; Z-Q D Xu; B Hamberger; T Hökfelt; S Ceccatelli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

3.  Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe.

Authors:  Erwan Le Maître; Swapnali Shantaram Barde; Miklos Palkovits; Rochellys Diaz-Heijtz; Tomas G M Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

4.  Development of a high-throughput screening-compatible cell-based functional assay to identify small molecule probes of the galanin 3 receptor (GalR3).

Authors:  James Robinson; Anthony Smith; Emmanuel Sturchler; Sahba Tabrizifard; Theodore Kamenecka; Patricia McDonald
Journal:  Assay Drug Dev Technol       Date:  2013-10-12       Impact factor: 1.738

5.  Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice.

Authors:  Jefferson W Kinney; Grzegorz Starosta; Andrew Holmes; Craige C Wrenn; Rebecca J Yang; Ashley P Harris; Katharine C Long; Jacqueline N Crawley
Journal:  Learn Mem       Date:  2002 Jul-Aug       Impact factor: 2.460

6.  Depression-like behavior in rat: Involvement of galanin receptor subtype 1 in the ventral periaqueductal gray.

Authors:  Peng Wang; Hui Li; Swapnali Barde; Ming-Dong Zhang; Jing Sun; Tong Wang; Pan Zhang; Hanjiang Luo; Yongjun Wang; Yutao Yang; Chuanyue Wang; Per Svenningsson; Elvar Theodorsson; Tomas G M Hökfelt; Zhi-Qing David Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

7.  Visualization of a functionally enhanced GFP-tagged galanin R2 receptor in PC12 cells: constitutive and ligand-induced internalization.

Authors:  Sheng Xia; Svend Kjaer; Kang Zheng; Ping-Sheng Hu; Li Bai; Jun-Yong Jia; Rudolf Rigler; Aladdin Pramanik; Tao Xu; Tomas Hökfelt; Zhi-Qing David Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-07       Impact factor: 11.205

8.  Impairment of memory consolidation by galanin correlates with in vivo inhibition of both LTP and CREB phosphorylation.

Authors:  Jefferson W Kinney; Manuel Sanchez-Alavez; Alasdair M Barr; Jose R Criado; Jacqueline N Crawley; M Margarita Behrens; Steven J Henriksen; Tamas Bartfai
Journal:  Neurobiol Learn Mem       Date:  2009-06-14       Impact factor: 2.877

9.  Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse.

Authors:  Margaret A Smith-White; Tiina P Iismaa; Erica K Potter
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

Review 10.  Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease.

Authors:  J N Crawley
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.